iBio, Inc. — Director's Dealing 2012

Nov 21, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2012-03-01

Reporting Person: TERENCE RYAN E (Chief Scientific Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.38	2020-07-14	Common Stock (100000)		Direct
Stock Option (right to buy)	$1.96	2021-10-21	Common Stock (100000)		Direct

Footnotes

F1: The option vests in three equal annual installments, beginning on July 1, 2010.

F2: The option vests in three equal annual installments, beginning on July 1, 2011.